Mass Balance Recovery, Pharmacokinetics, Metabolite Identification and Profiling of 14C-labeled TS-142 in Healthy Adult Subjects.
Latest Information Update: 14 Jun 2021
At a glance
- Drugs Vornorexant (Primary)
- Indications Insomnia; Sleep disorders
- Focus Pharmacokinetics
- Sponsors Taisho Pharmaceutical
- 10 Jun 2021 Status changed from recruiting to completed.
- 28 Apr 2021 Status changed from not yet recruiting to recruiting.
- 25 Mar 2021 New trial record